Track the 젬백스 stock price and the full insider trade history of the company, a listed equity based in South Korea. Shares are listed on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 젬백스 has logged 153 reports. Market capitalisation: €490.6bn. The latest transaction was filed on 31 August 2026 (Purchase). Among the most active insiders: 젬앤컴퍼니. All data is accessible without an account.
139
Insider Decl.
n/a
Thresholds
€3m
75 ops.
Buy Volume
€2m
18 ops.
Sell Volume
11Σ signal
Buys €3m€2m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 22,196 of 29,156 companies
33.7
score / 100
Value
32
Quality
36
FCF yld-0.2%
Earn yld-2.4%
EV/EBITDA·
ROE·
Gross mgn43%
Net mgn-14%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Gemvax is a company operating in the health and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative treatments and therapeutic solutions.